Paclitaxel and weekly 24-hour infusion of 5-fluorouracil folinic acid in advanced gastric cancer

被引：0
|
作者：
Bokemeyer, C
Hartmann, JT
Lampe, CS
Clemens, MR
Quietzsch, D
Forkmann, L
Kanz, L
机构：
[1] Univ Tubingen, Med Ctr 2, Dept Hematol Oncol Immunol, D-72076 Tubingen, Germany
[2] Krankenanstalt Mutterhaus, Dept Internal Med, Trier, Germany
[3] Stadt Kliniken, Dept Internal Med, Chemnitz, Germany
来源：
SEMINARS IN ONCOLOGY | 1997年 / 24卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S96 / S100
页数：5
相关论文
共 50 条
  • [1] A phase II study of paclitaxel, weekly, 24-hour continuous infusion 5-fluorouracil, folinic acid and cisplatin in patients with advanced gastric cancer
    Kollmannsberger, C.
    Quietzsch, D.
    Haag, C.
    Lingenfelsers, T.
    Schroeder, M.
    Hartmann, J. T.
    Baronius, W.
    Hempel, V.
    Clemens, M.
    Kanz, L.
    Bokemeyer, C.
    BRITISH JOURNAL OF CANCER, 2000, 83 (04) : 458 - 462
  • [2] A phase II study of paclitaxel, weekly, 24-hour continuous infusion 5-fluorouracil, folinic acid and cisplatin in patients with advanced gastric cancer
    C Kollmannsberger
    D Quietzsch
    C Haag
    T Lingenfelser
    M Schroeder
    J T Hartmann
    W Baronius
    V Hempel
    M Clemens
    L Kanz
    C Bokemeyer
    British Journal of Cancer, 2000, 83 : 458 - 462
  • [3] Topotecan or a weekly 24-hour infusion in patients with advanced colorectal cancer pretreated with 5-fluorouracil/folinic acid.
    Quietzsch, D
    Baronius, W
    Jungberg, P
    Liebert, A
    TUMORDIAGNOSTIK & THERAPIE, 2000, 21 (03) : 68 - 75
  • [4] A phase II trial of paclitaxel and weekly 24 h infusion of 5-fluorouracil folinic acid in patients with advanced gastric cancer
    Bokemeyer, C
    Lampe, CS
    Clemens, MR
    Hartmann, JT
    Quietzsch, D
    Forkmann, L
    Kollmannsberger, C
    Kanz, L
    ANTI-CANCER DRUGS, 1997, 8 (04) : 396 - 399
  • [5] Comparison of a 48-hour infusion of 5-fluorouracil without folinic acid with 24-hour folinic acid/5-fluorouracil in patients with metastatic colorectal cancer refractory to bolus folinic acid/5-fluorouracil - A prospective cohort study
    Moehler, M
    Gutzler, F
    Steinmann, S
    Boehme, M
    Raeth, U
    Stremmel, W
    Galle, PR
    Rudi, J
    CHEMOTHERAPY, 2003, 49 (1-2) : 85 - 89
  • [6] Weekly high-dose 5-fluorouracil 24-hour infusion and intermediate-dose folinic acid bolus in metastatic colorectal cancer
    Stoffregen, C
    Zurborn, KH
    Boehme, V
    Schmid, A
    Lorenz, G
    Arendt, T
    Folsch, UR
    ONKOLOGIE, 1996, 19 (05): : 410 - 414
  • [7] PHASE-I TRIAL OF 5-FLUOROURACIL BY 24-HOUR INFUSION WEEKLY
    HAAS, NB
    HINES, JB
    HUDES, GR
    JOHNSTON, N
    OZOLS, RF
    ODWYER, PJ
    INVESTIGATIONAL NEW DRUGS, 1993, 11 (2-3) : 181 - 185
  • [8] A phase II trial of paclitaxel, cisplatin, and weekly 24 h infusion of 5-Fluorouracil (5-FU)/folinic acid (FA) in patients (pts) with advanced gastric cancer
    Kollmannsberger, C
    Quietzch, D
    Clemens, M
    Lampe, C
    Lingenfelser, T
    Hartmann, JT
    Kanz, L
    Bokemeyer, C
    ANNALS OF ONCOLOGY, 1998, 9 : 48 - 48
  • [9] A pilot study on intensive weekly 24-hour intra-arterial infusion with 5-fluorouracil and folinic acid for colorectal liver metastases
    Lorenz, M
    Staib-Sebler, E
    Gog, C
    Petrowsky, H
    Köhne, CH
    Encke, A
    ONCOLOGY, 1998, 55 (01) : 53 - 58
  • [10] Phase II study of weekly paclitaxel and 24-hour infusion of high-dose 5-fluorouracil and leucovorin in the treatment of recurrent or metastatic gastric cancer
    Yeh, KH
    Lu, YS
    Hsu, CH
    Lin, JF
    Hsu, C
    Kuo, SH
    Li, SJ
    Cheng, AL
    ONCOLOGY, 2005, 69 (01) : 88 - 95
12345